Tower Research Capital (TRC)’s Cartesian Growth Corp II RENE Stock Holding History
Bought
Maintained
Sold
Other funds holding RENE
MC
WRBC
FTCM
CA
Tower Research Capital (TRC)'s RENE Position: Q4 2024 in Review
Tower Research Capital (TRC) sold out of Cartesian Growth Corp II (RENE) in Q4 2024, closing a stake of 76 shares — an estimated $872 sold.
Tower Research Capital (TRC) first reported a position in RENE in Q1 2023 and held it in 6 quarters. The position peaked at $5.43K in Q3 2023. 19 funds tracked by Wall St. Rank hold RENE as of Q4 2024.
- Tower Research Capital (TRC) reported no remaining Cartesian Growth Corp II position as of Q4 2024 after selling out during the quarter.
- Tower Research Capital (TRC) sold 76 Cartesian Growth Corp II shares in Q4 2024, an estimated $872.
- Tower Research Capital (TRC) first reported a position in Cartesian Growth Corp II in Q1 2023 and held it in 6 quarters.
- Tower Research Capital (TRC)'s Cartesian Growth Corp II position peaked at $5.43K in Q3 2023.
- 19 funds tracked by Wall St. Rank held Cartesian Growth Corp II as of Q4 2024.
Based on Tower Research Capital (TRC)'s 13F filing for Q4 2024, filed 13 Feb 2025.